GAMMA Investing LLC boosted its stake in Cross Country Healthcare, Inc. (NASDAQ:CCRN - Free Report) by 1,164.0% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 29,944 shares of the business services provider's stock after purchasing an additional 27,575 shares during the quarter. GAMMA Investing LLC owned about 0.09% of Cross Country Healthcare worth $446,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Quadrant Capital Group LLC purchased a new position in shares of Cross Country Healthcare during the fourth quarter worth approximately $25,000. Plato Investment Management Ltd purchased a new position in shares of Cross Country Healthcare during the fourth quarter worth approximately $46,000. Mint Tower Capital Management B.V. purchased a new position in shares of Cross Country Healthcare in the fourth quarter worth $182,000. Guggenheim Capital LLC purchased a new position in shares of Cross Country Healthcare in the fourth quarter worth $201,000. Finally, Envestnet Asset Management Inc. purchased a new position in shares of Cross Country Healthcare in the fourth quarter worth $217,000. 96.03% of the stock is owned by hedge funds and other institutional investors.
Cross Country Healthcare Stock Performance
CCRN traded down $0.73 on Monday, hitting $13.30. The company had a trading volume of 272,208 shares, compared to its average volume of 575,602. The stock has a market capitalization of $435.97 million, a price-to-earnings ratio of -25.09, a P/E/G ratio of 4.30 and a beta of 0.37. The stock has a fifty day moving average price of $13.67 and a 200-day moving average price of $15.86. Cross Country Healthcare, Inc. has a 12-month low of $9.58 and a 12-month high of $18.50.
Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) last released its earnings results on Wednesday, May 7th. The business services provider reported $0.06 EPS for the quarter, topping analysts' consensus estimates of $0.04 by $0.02. Cross Country Healthcare had a positive return on equity of 2.56% and a negative net margin of 1.41%. Cross Country Healthcare's quarterly revenue was down 22.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.19 earnings per share. Analysts forecast that Cross Country Healthcare, Inc. will post 0.53 EPS for the current fiscal year.
Analyst Ratings Changes
CCRN has been the topic of a number of research analyst reports. Wall Street Zen initiated coverage on shares of Cross Country Healthcare in a research report on Thursday, May 15th. They set a "hold" rating on the stock. UBS Group dropped their target price on shares of Cross Country Healthcare from $18.61 to $16.50 and set a "neutral" rating on the stock in a report on Tuesday, May 13th. Finally, Barrington Research restated a "market perform" rating and set a $18.61 target price on shares of Cross Country Healthcare in a report on Tuesday, June 17th. Seven analysts have rated the stock with a hold rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $17.93.
Check Out Our Latest Report on Cross Country Healthcare
About Cross Country Healthcare
(
Free Report)
Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
See Also

Before you consider Cross Country Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.
While Cross Country Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.